Sharenet Sites 
Sharenet Sites
Purchase of shares by directors, company secretary and directors of a major subsidiary, award of matching shares
LIFE HEALTHCARE GROUP HOLDINGS LIMITED
(Incorporated in the Republic of South Africa)
(Registration number: 2003/002733/06)
ISIN: ZAE000145892
Share Code: LHC
(“Life Healthcare” or “the Company”)
PURCHASE OF SHARES BY DIRECTORS AND THE COMPANY SECRETARY AND BY DIRECTORS
OF A MAJOR SUBSIDIARY AND AWARD OF MATCHING SHARES IN TERMS OF THE LIFE
HEALTHCARE 2014 LONG TERM INCENTIVE PLAN (“LTIP”)
In compliance with the JSE Limited Listings Requirements, the following information is
disclosed:
Director : André Meyer
Company : Life Healthcare Group Holdings Limited
Nature of transaction : The group chief executive officer has been allotted
the right to 36 936 matched shares and purchased
21 793 Life Healthcare shares on-market in terms
of the LTIP (these shares are restricted for two
years and cannot be traded until vesting of the
matched shares occurs).
Date of transaction : 24 January 2017
Number of securities : 58 729
Class of securities : Ordinary shares
Purchase price : R35.0473
Highest price : R35.06
Lowest price : R34.75
Total value of transaction : R2 058 292.88 (of this value,
R763 785.81 was paid by the director and R1 294
507.07 paid by the Company)
Nature of interest : Direct Beneficial
Clearance obtained : Approval for the allocation and clearance to
transact has been given
Director : Petrus Phillippus van der Westhuizen
Company : Life Healthcare Group Holdings Limited
Nature of transaction : The group chief financial officer has been allotted
the right to 12 509 matched shares and purchased
7 381 Life Healthcare shares on-market in terms of
the LTIP (these shares are restricted for two years
and cannot be traded until vesting of the matched
shares occurs).
Date of transaction : 24 January 2017
Number of securities : 19 890
Class of securities : Ordinary shares
Purchase price : R35.0473
Highest price : R35.06
Lowest price : R34.75
Total value of transaction : R697 090.80 (of this value,
R258 684.12 was paid by the director and R438
406.68 paid by the Company)
Nature of interest : Direct Beneficial
Clearance obtained : Approval for the allocation and clearance to
transact has been given
Director : Christoffel Lourens Welthagen Bekker
Company : Life Healthcare Group (Proprietary) Limited a
major subsidiary of the Company
Nature of transaction : The chief operating officer – SA has been allotted
the right to 11 765 matched shares and purchased
6 941 Life Healthcare shares on-market in terms of
the LTIP (these shares are restricted for two years
and cannot be traded until vesting of the matched
shares occurs).
Date of transaction : 24 January 2017
Number of securities : 18 706
Class of securities : Ordinary shares
Purchase price : R35.0473
Highest price : R35.06
Lowest price : R34.75
Total value of transaction : R655 594.79 (of this value,
R243 263.31 was paid by the director and R412
331.48 paid by the Company)
Nature of interest : Direct Beneficial
Clearance obtained : Approval for the allocation and clearance to
transact has been given
Director : Kurt Aston Wylie
Company : Life Healthcare Group (Proprietary) Limited a
major subsidiary of the Company
Nature of transaction : The business operating executive-SA has been
allotted the right to 3 884 matched shares and
purchased 2 291 Life Healthcare shares on-market
in terms of the LTIP (these shares are restricted for
two years and cannot be traded until vesting of the
matched shares occurs).
Date of transaction : 24 January 2017
Number of securities : 6 175
Class of securities : Ordinary shares
Purchase price : R35.0473
Highest price : R35.06
Lowest price : R34.75
Total value of transaction : R216 417.08 (of this value,
R80 293.36 was paid by the director and R136
123.71 paid by the Company)
Nature of interest : Direct Beneficial
Clearance obtained : Approval for the allocation and clearance to
transact has been given
Director : Pieter Francois Theron
Company : Life Healthcare Group (Proprietary) Limited a
major subsidiary of the Company
Nature of transaction : The chief financial officer-SA has been allotted the
right to 6 241 matched shares and purchased 3
682 Life Healthcare shares on-market in terms of
the LTIP (these shares are restricted for two years
and cannot be traded until vesting of the matched
shares occurs).
Date of transaction : 24 January 2017
Number of securities : 9 923
Class of securities : Ordinary shares
Purchase price : R35.0473
Highest price : R35.06
Lowest price : R34.75
Total value of transaction : R347 774.36 (of this value,
R129 044.16 was paid by the director and R218
730.20 paid by the Company)
Nature of interest : Direct Beneficial
Clearance obtained : Approval for the allocation and clearance to
transact has been given
Company Secretary : Fazila Patel
Company : Life Healthcare Group Holdings Limited
Nature of transaction : The company secretary has been allotted the right
to 7 605 matched shares and purchased 4 487 Life
Healthcare shares on-market in terms of the LTIP
(these shares are restricted for two years and
cannot be traded until vesting of the matched
shares occurs).
Date of transaction : 24 January 2017
Number of securities : 12 092
Class of securities : Ordinary shares
Purchase price : R35.0473
Highest price : R35.06
Lowest price : R34.75
Total value of transaction : R423 791.95 (of this value,
R157 257.24 was paid by the company secretary
and R266 534.72 was paid by the Company)
Nature of interest : Direct Beneficial
Clearance obtained : Approval for the allocation and clearance to
transact has been given
Illovo
27 January 2016
Sponsor
RAND MERCHANT BANK (A division of FirstRand Bank Limited)
Date: 27/01/2017 08:12:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
